In March, Brentwood-based PharmMD, a leading medication adherence technology solutions company, announced Jason Rose has joined the company as chief executive officer and member of its board of directors.
PharmMD's Chairman, Frank Coliano, stated, "After a thorough and thoughtful search process, we are thrilled to have Jason join us as CEO and a member of our board. Jason brings a stellar leadership reputation, a wealth of healthcare technology experience, and a lifelong passion for innovation - all of which are critical components in the evolution of our company."
Bob Yeager, who had served as the company's CEO for five years, will remain on the board. According to Yeager, "The board, including myself, has always had a strong focus on succession planning. We initiated the formal CEO succession process many months ago, searching to find the best leader for our employees, customers, partners and shareholders. We all agree that person is Jason. I'm equally pleased to continue my support of this incredible company into the future."
Rose joins PharmMD with nearly 25 years of healthcare technology experience with extensive background leading, innovating and scaling healthcare solutions, including several high growth companies. He previously held leadership roles at Inovalon, Inspiris, Ardent Health Services, Cap Gemini Ernst & Young and Cerner.